Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study.

Abe, Marina; Shoji, Tadahiro; Chiba, Yohei; Takatori, Eriko; Kaido, Yoshitaka; Nagasawa, Takayuki; Kagabu, Masahiro; Takahashi, Fumiaki; Aida, Takeshi; Baba, Tsukasa

Abe, Marina; Shoji, Tadahiro; Chiba, Yohei; Takatori, Eriko; Kaido, Yoshitaka; Nagasawa, Takayuki; Kagabu, Masahiro; Takahashi, Fumiaki; Aida, Takeshi; Baba, Tsukasa.

Afiliação

Abe M; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
Shoji T; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan; tshoji@iwate-med.ac.jp.
Chiba Y; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
Takatori E; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
Kaido Y; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
Nagasawa T; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
Kagabu M; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
Takahashi F; Department of Information Science, Iwate Medical University, Iwate, Japan.
Aida T; Department of Obstetrics and Gynecology, Hachinohe Red Cross Hospital, Aomori, Japan.
Baba T; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.

Anticancer Res ; 43(3): 1265-1272, 2023 Mar.

Article em En | MEDLINE | ID: mdl-36854492

Assuntos

Neutropenia; Neoplasias Ovarianas; Trombocitopenia; Feminino; Humanos; Inibidores de Poli(ADP-Ribose) Polimerases/efeitos adversos; Bevacizumab/efeitos adversos; Estudos Retrospectivos; Platina; Carboplatina/efeitos adversos; Tubas Uterinas; Carcinoma Epitelial do Ovário; Paclitaxel; Neoplasias Ovarianas/tratamento farmacológico; Adenosina Difosfato Ribose

Palavras-chave

Ovarian cancer; PARP inhibitors; bevacizumab; chemotherapy; platinum-sensitive recurrence

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Trombocitopenia / Neutropenia Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google